Smart Pills Drug Delivery Market to record 16.97% Y-O-Y Growth Rate in 2022 | Driven by Rising Prevalence of Chronic Diseases | Technavio

Drivers - The key factor driving the global smart pills drug delivery industry growth is the rising prevalence of chronic diseases. As the various bio-physiological factors limit the efficacy of targeted therapy for chronic diseases such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's disease, and Alzheimer's disease, many new drug delivery systems are in high demand to improve drug efficacy. Non-long-acting drug delivery systems (LADDS), for example, are used to treat chronic diseases. For instance, non-long-acting drug delivery systems (LADDS) treat chronic diseases. The technology delivers drug molecules into target tissues through systemic circulation or localized injections. Such factors will drive the growth of the market during the forecast period.

Challenges -  The key challenge to the global smart pills drug delivery industry growth is the stringent regulations. Safety, efficacy, pharmacological data, pharmacodynamic effects, and drug interactions are some of the key factors that are examined by the regulatory bodies. Therefore, a drug failing in these criteria is likely to receive a complete response letter (CRL) or may face complete rejection from regulatory agencies. On receiving a CRL, a drug applicant is required to furnish additional data about the drug, which may require additional clinical trials and may increase the R and D expenditure of the drug. In some cases, the drug applicants withdraw their applications and discontinue their drug trials. Such factors can hamper the growth of the global smart pills drug delivery market during the forecast period.

To know about more drivers & challenges - Download a free sample now!

Company Profiles

The smart pills drug delivery market is concentrated and the vendors are deploying growth strategies such as investment in R and D activities to compete in the market. The smart pills drug delivery market report provides complete insights on key vendors including CapsoVision Inc., Check-Cap Ltd., etectRx, General Electric Co., HQ Inc, Insulet Corp., IntroMedic Co. Ltd., Jinshan Science and Technology Group Co. Ltd., Koninklijke Philips NV, Medtronic Plc, Olympus Europa SE and Co. KG, and Otsuka Holdings Co. Ltd.

To know about the vendor offerings - Download a free sample now!

Competitive Analysis

The competitive scenario provided in the smart pills drug delivery market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

 Segmentation Analysis

• By Application, the market is classified as capsule endoscopy, drug delivery, and patient monitoring. The smart pills drug delivery market share growth by the capsule endoscopy segment will be significant for revenue generation. The ongoing improvements in the field of endoscopy and the increased demand for accurate diagnosis of gastrointestinal problems are expected to drive the growth of the market during the forecast years.
  
  
• By Geography, the market is classified as North America, Europe, Asia, and the Rest of the World (ROW). North America will have the largest share of the market. 40% of the market's growth will originate from North America during the forecast period. The US is the key market for smart pills drug delivery in North America. However, market growth in this region will be slower than the growth of the market in other regions. The high technology penetration, increase in chronic disorders such as cancer, diabetes, and others, and surge in prevalence of lifestyle-related disorders, such as obesity, gastroesophageal reflux disease (GERD), and gastric ulcers will facilitate the smart pills drug delivery market growth in North America over the forecast period.

To know about the market contribution of each segment - Download a free sample now!

Related Reports

• The thrombosis drugs market share is expected to increase by USD 16.24 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.67%. Download a free sample now!
  
  
• The anticoagulant reversal drugs market share is expected to increase by USD 877.37 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 12.27%. Download a free sample now!

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Capsule endoscopy - Market size and forecast 2021-2026
• Exhibit 28: Chart on Capsule endoscopy - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Capsule endoscopy - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Capsule endoscopy - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Capsule endoscopy - Year-over-year growth 2021-2026 (%)

• 5.4 Drug delivery - Market size and forecast 2021-2026
• Exhibit 32: Chart on Drug delivery - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Drug delivery - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Drug delivery - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Drug delivery - Year-over-year growth 2021-2026 (%)

• 5.5 Patient monitoring - Market size and forecast 2021-2026
• Exhibit 36: Chart on Patient monitoring - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Patient monitoring - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Patient monitoring - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Patient monitoring - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Application
• Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 UK - Market size and forecast 2021-2026
• Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.9 Japan - Market size and forecast 2021-2026
• Exhibit 70: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.10 Germany - Market size and forecast 2021-2026
• Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.11 France - Market size and forecast 2021-2026
• Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification

• 10.3 CapsoVision Inc.
• Exhibit 89: CapsoVision Inc. - Overview
• Exhibit 90: CapsoVision Inc. - Product / Service
• Exhibit 91: CapsoVision Inc. - Key offerings

• 10.4 Check-Cap Ltd.
• Exhibit 92: Check-Cap Ltd. - Overview
• Exhibit 93: Check-Cap Ltd. - Product / Service
• Exhibit 94: Check-Cap Ltd. - Key offerings

• 10.5 etectRx
• Exhibit 95: etectRx - Overview
• Exhibit 96: etectRx - Product / Service
• Exhibit 97: etectRx - Key offerings

• 10.6 HQ Inc
• Exhibit 98: HQ Inc - Overview
• Exhibit 99: HQ Inc - Product / Service
• Exhibit 100: HQ Inc - Key offerings

• 10.7 IntroMedic Co. Ltd.
• Exhibit 101: IntroMedic Co. Ltd. - Overview
• Exhibit 102: IntroMedic Co. Ltd. - Product / Service
• Exhibit 103: IntroMedic Co. Ltd. - Key offerings

• 10.8 Jinshan Science and Technology Group Co. Ltd.
• Exhibit 104: Jinshan Science and Technology Group Co. Ltd. - Overview
• Exhibit 105: Jinshan Science and Technology Group Co. Ltd. - Product / Service
• Exhibit 106: Jinshan Science and Technology Group Co. Ltd. - Key offerings

• 10.9 Koninklijke Philips NV
• Exhibit 107: Koninklijke Philips NV - Overview
• Exhibit 108: Koninklijke Philips NV - Business segments
• Exhibit 109: Koninklijke Philips NV - Key news
• Exhibit 110: Koninklijke Philips NV - Key offerings
• Exhibit 111: Koninklijke Philips NV - Segment focus

• 10.10 Medtronic Plc
• Exhibit 112: Medtronic Plc - Overview
• Exhibit 113: Medtronic Plc - Business segments
• Exhibit 114: Medtronic Plc - Key news
• Exhibit 115: Medtronic Plc - Key offerings
• Exhibit 116: Medtronic Plc - Segment focus

• 10.11 Olympus Europa SE and Co. KG
• Exhibit 117: Olympus Europa SE and Co. KG - Overview
• Exhibit 118: Olympus Europa SE and Co. KG - Product / Service
• Exhibit 119: Olympus Europa SE and Co. KG - Key offerings

• 10.12 Otsuka Holdings Co. Ltd.
• Exhibit 120: Otsuka Holdings Co. Ltd. - Overview
• Exhibit 121: Otsuka Holdings Co. Ltd. - Business segments
• Exhibit 122: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibit 123: Otsuka Holdings Co. Ltd. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 124: Inclusions checklist
• Exhibit 125: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 126: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 127: Research methodology
• Exhibit 128: Validation techniques employed for market sizing
• Exhibit 129: Information sources

• 11.5 List of abbreviations
• Exhibit 130: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio